跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Januglip 100 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Januglip 100
Approved
STANDARD
Januglip 100
Hebei Tiancheng Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ab71edd48c1de46a
Company
Hebei Tiancheng Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
ab71edd48c1de46a
Drug Approval Philippines Name
Januglip 100
Product Name
Januglip 100
Registration Number
DRP-10623-02
Brand Name
Januglip 100
Generic Name
Sitagliptin (as phosphate)
Dosage Form
Tablet
Dosage Strength
100 mg
Manufacturer
Hebei Tiancheng Pharmaceutical Co., Ltd
Importer
AMB HK Enterprises Inc.
Distributor
FSPC Pharmaceuticals Inc.
Issuance Date
28 February 2022
Expiry Date
28 October 2026
Pharmacologic Category
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ab71edd48c1de46a
Type
Standard
Back to Philippines FDA Approvals